Nanopore Technologies Market Growth, Demand and Challenges of the Key Industry Players 2024-32
                     Global Nanopore 
Technologies Market 
Research and Forecast 
Report 2024-2032
Format: PDF+EXCEL
© 2023 IMARC All Rights Reserved 
About IMARC Group
In ternat ional  Market  Analys is  Research and Consul t ing Group is  a leading adv iser  on management  
s t rategy and market  research wor ldwide.  We par tner  wi th c l ients  in  a l l  regions and indust ry  
vert ica ls  to  ident i fy  thei r  h ighest -value oppor tuni t ies,  address thei r  most  cr i t ica l  chal lenges,  and 
t ransform thei r  bus inesses.
IMARC’s in format ion products  inc lude major market ,  sc ient i f ic ,  economic and technological  
developments  for  bus iness leaders  in  pharmaceut ica l ,  indust r ia l ,  and h igh technology 
organizat ions.  Market  forecasts  and indust ry  analys is  for  b iotechnology,  advanced mater ia ls ,  
chemicals ,  food and beverage,  t ravel  and tour ism, nanotechnology and novel  process ing methods 
are at  the top of  the company’s  exper t ise.
IMARC’s ta i lored approach combines unfathomable ins ight  in to the dynamics o f  companies and 
markets wi th c lose cooperat ion at  a l l  levels  of  the c l ient  organizat ion.  This ensures that  our  c l ients 
achieve unmatchable compet i t ive advantage,  bui ld  more pro f ic ient  organizat ions,  and secure 
las t ing resul ts .
Accord ing  t o  t he  la tes t  r epo r t  by  I MARC G roup ,  t i t l ed  "Nanopore  Technol og ies  
Market :  G l oba l  Indust ry  T rends ,  Share ,  S ize ,  Growth ,  O pportun i ty  and  
Forecast  2024-2032 ,"  t he  g loba l  nanopore  techno log ies  marke t  s i ze  reached  US$  
276 .4  M i l l i on  in  2023.
Report Nanopore  techno log ies  re fe r  t o  t he  nex t -genera t i on  mo lecu le  sequenc ing  met hods  tha t  a re  genera l l y  used f o r  ana lyz ing  r ibonuc le i c  ac id  (RNA)  o r  deoxy r ibonuc le i c  
ac id  (DNA)  f ragment s .  I t  i nvo lves  t he  u t i l i za t i on  o f  sequenc ing  dev i ces  t ha t  
Highlight and con ta in  nano-s ized  pores  em bedded  in  an  e lec t ro - res i s t an t  membrane  fo r  
de te rm in ing  t he  sequence and  mod i f i ca t ions  o f  t he  bases .  
Description Along  w i t h  t h i s ,  i t  a ids  in  t he  rea l - t ime  ana lys is  o f  t he  sequence o f  nuc leo t ides  w i th  accura te  da t a  o f  sho r t  t o  long  f ragmen ts  o f  na t i ve  RNA o r  DNA.  As  a  resu l t ,  
i t  i s  ex t ens ive ly  u t i l i zed  by  sc ien t i f i c  researchers  t o  s t udy  the  b io logy  o f  an ima ls ,  
p lan ts ,  pa thogens  and  humans .
Request  fo r  a  PDF sample  o f  th is  repor t :  
ht tps : / / www. imarcgroup .com/nanopore- techno log ies -marke t / reques t samp le
Report Description
G l o b a l  N a n o p o r e  T e c h n o l o g i e s  M a r k e t  T r e n d s :
T h e  g l o b a l  m a r k e t  i s  p r i m a r i l y  d r i v e n  b y  t h e  r i s i n g  d e m a n d  f o r  D N A  s e q u e n c i n g .  T h i s  i s  i m p e l l e d  b y  t h e  g r o w i n g  n e e d  f o r  n e w  t r e a t m e n t  
m e t h o d s  d u e  t o  t h e  e s c a l a t i n g  p r e v a l e n c e  o f  v i r a l  d i s e a s e s  a m o n g  t h e  m a s s e s .  I n  l i n e  w i t h  t h i s ,  t h e  r a p i d  o u t b r e a k  o f  c o r o n a v i r u s  
d i s e a s e  ( C O V I D - 1 9 )  h a s  f u r t h e r  p r o p e l l e d  t h e  m a r k e t  g r o w t h .  S i n c e  n a n o p o r e  t e c h n o l o g i e s  o f f e r  d i r e c t  m o l e c u l a r  a n a l y s i s  i n  a  t i m e -  
a n d  c o s t - e f f i c i e n t  m a n n e r  w h i l e  g e n e r a t i n g  a c c u r a t e  r e s u l t s ,  t h i s  i s  p r o v i d i n g  a  b o o s t  t o  t h e i r  u p t a k e .  A l o n g  w i t h  t h i s ,  e x t e n s i v e  
r e s e a r c h  a n d  d e v e l o p m e n t  ( R & D )  a c t i v i t i e s  c o n d u c t e d  f o r  s t u d y i n g  n o v e l  v i r u s  v a r i a n t s  a r e  c r e a t i n g  a  p o s i t i v e  m a r k e t  o u t l o o k .  
F u r t h e r m o r e ,  c o n t i n u a l  t e c h n o l o g i c a l  a d v a n c e m e n t s ,  s u c h  a s  t h e  i n t e g r a t i o n  o f  t h e  I n t e r n e t  o f  T h i n g s  ( I o T )  a n d  c o m p u t a t i o n a l  
i n t e l l i g e n c e  w i t h  n a n o p o r e  t e c h n o l o g y ,  a r e  c o n s i d e r e d  t o  b e  m a j o r  g r o w t h - i n d u c i n g  f a c t o r s .  A d d i t i o n a l l y ,  t h e  w i d e s p r e a d  a d o p t i o n  o f  
n a n o p o r e  t e c h n o l o g y  i n  t h e  d e v e l o p m e n t  o f  s e m i c o n d u c t o r - b a s e d  s i l i c o n  m o l e c u l a r  d e t e c t o r s  f o r  p e r f o r m i n g  s e q u e n c i n g  i s  s i g n i f i c a n t l y  
c o n t r i b u t i n g  t o  t h e  m a r k e t .  O t h e r  f a c t o r s ,  i n c l u d i n g  t h e  i n c r e a s i n g  n u m b e r  o f  r e s e a r c h  c e n t e r s  a n d  l a b o r a t o r i e s ,  m i n i a t u r i z a t i o n  o f  
n a n o p o r e  d e v i c e s ,  a n d  c o n t i n u o u s  i m p r o v e m e n t s  i n  t h e  h e a l t h c a r e  i n f r a s t r u c t u r e ,  a r e  a l s o  f a v o r a b l y  i m p a c t i n g  t h e  m a r k e t .
L o o k i n g  f o r w a r d ,  t h e  m a r k e t  i s  a n t i c i p a t e d  t o  r e a c h  a  v a l u e  o f  U S $  7 5 3 . 6  M i l l i o n  b y  2 0 3 2 ,  e x h i b i t i n g  a  C A G R  o f  1 1 . 4 %  d u r i n g  
2 0 2 4 - 2 0 3 2 .
V i e w  R e p o r t  T O C ,  F i g u r e s  a n d  T a b l e s :  h t t p s : / / w w w . i m a r c g r o u p . c o m / n a n o p o r e - t e c h n o l o g i e s - m a r k e t
Breakup by Product:
• Instruments
o Portable
o Benchtop
• Consumables
 
Report Breakup by Application:
• DNA Sequencing
Segmentation
• RNA Sequencing
• Others
Breakup by End User:
• Hospita ls and Cl inics
• Research Inst i tutes
• Others
Breakup by Region:
• North America
Report • Asia-Pacifi c
• Europe
Segmentation
• Latin America
• Middle East and Afr ica
• Agi lent Technologies Inc.
• Cyclomics BV
• Electronic Biosciences Inc.
Competitive • Inanobio Inc.
Landscape • Nabsys Inc.
• Ontera Inc.
with Key • Oxford Nanopore Technologies Limited
Players • Pacifi c Biosciences of Cal i fornia Inc.
• Quantapore Inc.
• Roche Holding AG
• Tracxn Technologies Limited.
How big is the global nanopore technologies market?
What is the expected growth rate of the global 
nanopore technologies market during 2024-2032?
What are the key factors driving the global nanopore 
technologies market?
Key 
What has been the impact of COVID-19 on the global 
nanopore technologies market?
Questions 
What is the breakup of the global nanopore 
Answered in technologies market based on the product?
the Report What is the breakup of the global nanopore 
technologies market based on the application?
What is the breakup of the global nanopore 
technologies market based on the end user?
What are the key regions in the global nanopore 
technologies market?
Who are the key players/companies in the global 
nanopore technologies market?
1     P r e f a c e
2     S c o p e  a n d  M e t h o d o l o g y
    2 . 1     O b j e c t i v e s  o f  t h e  S t u d y
    2 . 2     S t a k e h o l d e r s
    2 . 3     D a t a  S o u r c e s
        2 . 3 . 1     P r i m a r y  S o u r c e s
        2 . 3 . 2     S e c o n d a r y  S o u r c e s
    2 . 4     M a r k e t  E s t i m a t i o n
Table of         2 . 4 . 1     B o t t o m - U p  A p p r o a c h        2 . 4 . 2     T o p - D o w n  A p p r o a c h    2 . 5     F o r e c a s t i n g  M e t h o d o l o g y
3     E x e c u t i v e  S u m m a r y
4     I n t r o d u c t i o n
Contents     4 . 1     O v e r v i e w    4 . 2     K e y  I n d u s t r y  T r e n d s
5     G l o b a l  N a n o p o r e  T e c h n o l o g i e s  M a r k e t
    5 . 1     M a r k e t  O v e r v i e w
    5 . 2     M a r k e t  P e r f o r m a n c e
    5 . 3     I m p a c t  o f  C O V I D - 1 9
    5 . 4     M a r k e t  F o r e c a s t
6      M a r k e t  B r e a k u p  b y  P r o d u c t
    6 . 1     I n s t r u m e n t s
        6 . 1 . 1  M a r k e t  T r e n d s
        6 . 1 . 2  K e y  S e g m e n t s
           6 . 1 . 2 . 1  P o r t a b l e
           6 . 1 . 2 . 2  B e n c h t o p
        6 . 1 . 3  M a r k e t  F o r e c a s t
    6 . 2     C o n s u m a b l e s
        6 . 2 . 1  M a r k e t  T r e n d s
        6 . 2 . 2  M a r k e t  F o r e c a s t
       
7    M a r k e t  B r e a k u p  b y  A p p l i c a t i o n
    7 . 1     D N A  S e q u e n c i n g
        7 . 1 . 1  M a r k e t  T r e n d s
        7 . 1 . 2  M a r k e t  F o r e c a s t
    7 . 2     R N A  S e q u e n c i n g
        7 . 2 . 1  M a r k e t  T r e n d s
        7 . 2 . 2  M a r k e t  F o r e c a s t
    7 . 3     O t h e r s
        7 . 3 . 1  M a r k e t  T r e n d s
        7 . 3 . 2  M a r k e t  F o r e c a s t
Table of 8    M a r k e t  B r e a k u p  b y  E n d  U s e r    8 . 1     H o s p i t a l s  a n d  C l i n i c s
        8 . 1 . 1  M a r k e t  T r e n d s
        8 . 1 . 2  M a r k e t  F o r e c a s t
Contents     8 . 2     R e s e a r c h  I n s t i t u t e s
        8 . 2 . 1  M a r k e t  T r e n d s
        8 . 2 . 2  M a r k e t  F o r e c a s t
    8 . 3     O t h e r s
        8 . 3 . 1  M a r k e t  T r e n d s
        8 . 3 . 2  M a r k e t  F o r e c a s t
9    M a r k e t  B r e a k u p  b y  R e g i o n
    9 . 1     N o r t h  A m e r i c a
        9 . 1 . 1  U n i t e d  S t a t e s
           9 . 1 . 1 . 1  M a r k e t  T r e n d s
           9 . 1 . 1 . 2  M a r k e t  F o r e c a s t
        9 . 1 . 2  C a n a d a
           9 . 1 . 2 . 1  M a r k e t  T r e n d s
           9 . 1 . 2 . 2  M a r k e t  F o r e c a s t     
F o r  m o r e  i n f o r m a t i o n ,  v i s i t :  
ht t ps : / /w ww. i ma rc gro up . c o m /n a no po re - tec hno lo g i e s -m a rke t / t
o c
Disclaimer
© 2023  IMARC Al l  R ights  Reserved 
Th is  Pub l i ca t ion  and  a l l  i t ’ s  con ten ts  un less  o therw ise  men t i oned  a re  copy r i gh ted  in  the  name o f  
I n t e rna t i ona l  Marke t  Ana lys i s  Research  and  Consu l t ing  ( IMARC) .  No  pa r t  o f  t h i s  pub l i ca t ion  may  be  
rep roduced ,  repackaged ,  red i s t r i bu ted  o r  res o ld  i n  who le  o r  i n  any  pa r t .  The  pub l i ca t ion  may  a l so  
no t  be  used  i n  any  f o rm o r  by  and means  g raph i c  e lec t ron ic  o r  mechan ic a l ,  i nc lud ing  pho tocopy ing ,  
reco rd ing ,  t ap ing  o r  by  i n fo rmat i on  s to rage  o r  re t r ieva l ,  o r  by  any  o the r  f o rm,  w i t hou t  the  exp ress  
c ons en t  o f  I n t e rna t iona l  Marke t  Ana lys i s  Research  and  Consu l t i ng  ( IMARC) .
Disc la imer :  Al l  con ten ts  and  da ta  o f  t h i s  pub l i c a t i on ,  i nc lud ing  fo recas t s ,  da ta  ana lys i s  and  op in ion  
have  been  based  on  in f o rmat ion  and  sources  be l ieved  to  be  accu ra te  and  re l iab le  a t  t he  t ime  o f  
pub l i sh ing .  In t e rna t i ona l  Ma rke t  Ana l ys is  Research  and  Consu l t ing  makes  no  rep resen ta t ion  o f  
war ran t y  o f  any  k ind  as  to  t he  acc u racy  o r  comp le teness  o f  any  I n fo rmat i on  p rov ided .  IMARC 
accep ts  no  l i ab i l i t y  wha tsoever  f o r  any  los s  o r  damage  resu l t i ng  f rom op in ion ,  e r ro rs  o r  
i naccu rac ies  i f  any  f ound  th is  pub l i ca t ion .
IMARC,  IMARC Group  and  G loba l  Therapy  I ns igh t  Ser i es  a re  reg is t e red  t rademarks  o f  I n te rna t iona l  
Marke t  Ana lys i s  Research  and  Consu l t ing .  A l l  o the r  t rademarks  used  i n  th i s  pub l i ca t i on  a re  
reg i s te red  t rademarks  o f  t he i r  r espec t i ve  compan ies .
Contact Us
Visit us at :
https://www.imarcgroup.com
TELEPHONE: +1-631-791-1145 
E-MAIL: [email protected]